NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
November 8, 2005 • Volume 2 / Number 43 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

The information and links on this page are no longer being updated and are provided for reference purposes only.

Featured Article

After Treatment: The Needs of Cancer Survivors

A new report by the Institute of Medicine (IOM) concludes that a growing number of cancer patients are surviving the disease only to face a constellation of new needs and that too often these needs are not met. The 500-page report, based on an extensive review of the scientific literature and interviews with survivors, proposes recommendations for improving the care and quality of life for these individuals.

A primary recommendation is that all cancer patients be given summaries of their medical treatments and instructions for follow-up care once they complete therapy. These survivor care plans would document which treatments a patient had and which health changes should be monitored closely.

"A care plan is a concrete step that could be taken tomorrow and would provide relief essentially immediately," says Dr. Sheldon Greenfield, who directs the Center for Health Policy Research at the University of California, Irvine, and co-led the panel that produced the report, From Cancer Patient to Cancer Survivor: Lost in Transition.  Read more  

Director's Update

Guest Update by Dr. Ernie Hawk

TRWG Process Moving Forward, Members Named

Since being named by Dr. von Eschenbach earlier this year to chair the Translational Research Working Group (TRWG), I have come to more fully appreciate the potential of the working group to influence how we approach translational research. We will evaluate the translational research components of the National Cancer Institute's (NCI's) current portfolio and provide a blueprint for how best to harness our translational research resources. Our goal is to ensure that the processes and programs are in place at NCI to rapidly translate the scientific discoveries of the cancer community's many dedicated scientists into new interventions for preventing, diagnosing, and treating cancer.

There will be broad public input into the TRWG deliberations, including participation in the working group by many of the country's leading translational researchers, as well as representatives from the advocacy community, industry, the Food and Drug Administration (FDA), and NCI staff. In fact, the complete 60-member TRWG roster is now available on the working group's Web site at www.cancer.gov/trwg.

In naming the members, I worked with the TRWG co-chairs, Drs. Lynn Matrisian and William G. Nelson, to select as representative a group as possible, while still ensuring it was of a manageable size.
 Read more  


The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI). NCI, which was established in 1937, leads the national effort to eliminate the suffering and death due to cancer. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information on cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.

NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.